{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T09:41:00Z","timestamp":1756460460212},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologe"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1007\/s00292-006-0883-5","type":"journal-article","created":{"date-parts":[[2007,1,8]],"date-time":"2007-01-08T06:32:17Z","timestamp":1168237937000},"page":"29-35","source":"Crossref","is-referenced-by-count":5,"title":["Sind prim\u00e4r extranodale diffuse gro\u00dfzellige B-Zell-Lymphome organotypische Erkrankungen?"],"prefix":"10.1007","volume":"28","author":[{"given":"G.","family":"Ott","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Rosenwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"883_CR1","unstructured":"Jaffe ES, Harris NL, Stein H, Vardiman JW (eds) (2001) World Health Organization Classification of Tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. IARC, Lyon"},{"key":"883_CR2","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa055759","volume":"354","author":"Dave","year":"2006","unstructured":"Dave SS, Fu K, Wright GW et al. (2006) Molecular diagnosis of Burkitt\u2019s lymphoma. N Engl J Med 354: 2431\u20132442","journal-title":"N Engl J Med"},{"key":"883_CR3","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa055351","volume":"354","author":"Hummel","year":"2006","unstructured":"Hummel M, Bentink S, Berger H et al. (2006) A biologic definition of Burkitt\u2019s lymphoma from transcriptional and genomic profiling. N Engl J Med 354: 2419\u20132430","journal-title":"N Engl J Med"},{"key":"883_CR4","doi-asserted-by":"crossref","first-page":"6351","DOI":"10.1200\/JCO.2005.05.012","volume":"23","author":"Lossos","year":"2005","unstructured":"Lossos IS (2005) Molecular pathogenesis of diffuse large B-cell lymphoma. J Clin Oncol 23: 6351\u20136357","journal-title":"J Clin Oncol"},{"key":"883_CR5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0002-9440(10)63313-5","volume":"165","author":"Katzenberger","year":"2004","unstructured":"Katzenberger T, Ott G, Klein T et al. (2004) Cytogenetic alterations affecting BCL6 are predominantly found in follicular lymphomas grade 3B with a diffuse large B-cell component. Am J Pathol 165: 481\u2013490","journal-title":"Am J Pathol"},{"key":"883_CR6","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1182\/blood-2005-04-1399","volume":"106","author":"Bea","year":"2005","unstructured":"Bea S, Zettl A, Wright G et al. (2005) Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene expression-based survival prediction. Blood 106: 3183-3190","journal-title":"Blood"},{"key":"883_CR7","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","volume":"346","author":"Rosenwald","year":"2002","unstructured":"Rosenwald A, Wright G, Chan WC et al. (2002) The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346: 1937\u20131947","journal-title":"N Engl J Med"},{"key":"883_CR8","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1182\/blood.V87.4.1571.bloodjournal8741571","volume":"87","author":"Joos","year":"1996","unstructured":"Joos S, Otano-Joos MI, Ziegler S et al. (1996) Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. Blood 87: 1571\u20131578","journal-title":"Blood"},{"key":"883_CR9","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1182\/blood-2004-09-3701","volume":"105","author":"Melzner","year":"2005","unstructured":"Melzner I, Bucur AJ, Bruderlein S et al. (2005) Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line. Blood 105: 2535\u20132542","journal-title":"Blood"},{"key":"883_CR10","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20031074","volume":"198","author":"Rosenwald","year":"2003","unstructured":"Rosenwald A, Wright G, Leroy K et al. (2003) Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med 198: 851\u2013862","journal-title":"J Exp Med"},{"key":"883_CR11","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1200\/JCO.2001.19.18.3861","volume":"19","author":"Koch","year":"2001","unstructured":"Koch P, del Valle F, Berdel WE et al. (2001) Primary gastrointestinal non-Hodgkin\u2019s lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01\/92. J Clin Oncol 19: 3861\u20133873","journal-title":"J Clin Oncol"},{"key":"883_CR12","first-page":"181","volume":"11","author":"Omonishi","year":"1998","unstructured":"Omonishi K, Yoshino T, Sakuma I et al. (1998) bcl-6 protein is identified in high-grade but not low-grade mucosa-associated lymphoid tissue lymphomas of the stomach. Mod Pathol 11: 181\u2013185","journal-title":"Mod Pathol"},{"key":"883_CR13","first-page":"3944","volume":"57","author":"Ott","year":"1997","unstructured":"Ott G, Katzenberger T, Greiner A et al. (1997) The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin\u2019s lymphomas of the mucosa-associated lymphoid tissue (MALT-) type. Cancer Res 57: 3944\u20133948","journal-title":"Cancer Res"},{"key":"883_CR14","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1182\/blood-2006-05-022517","volume":"108","author":"Chen","year":"2006","unstructured":"Chen YW, Hu XT, Liang AC et al. (2006) High BCL6 expression predicts better prognosis, independent of BCL6 translocation status, translocation partner, or BCL6-deregulating mutations, in gastric lymphoma. Blood 108: 2373\u20132383","journal-title":"Blood"},{"key":"883_CR15","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1182\/blood.V91.11.4321","volume":"91","author":"Barth","year":"1998","unstructured":"Barth TF, Dohner H, Werner CA et al. (1998) Characteristic pattern of chromosomal gains and losses in primary large B-cell lymphomas of the gastrointestinal tract. Blood 91: 4321\u20134330","journal-title":"Blood"},{"key":"883_CR16","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1182\/blood.V76.4.797.797","volume":"76","author":"van","year":"1990","unstructured":"van Krieken JH, Raffeld M, Raghoebier S et al. (1990) Molecular genetics of gastrointestinal non-Hodgkin\u2019s lymphomas: unusual prevalence and pattern of c-myc rearrangements in aggressive lymphomas. Blood 76: 797\u2013800","journal-title":"Blood"},{"key":"883_CR17","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/sj.leu.2404244","volume":"20","author":"Haralambieva","year":"2006","unstructured":"Haralambieva E, Adam P, Ventura R et al. (2006) Genetic rearrangement of FOXP1 is predominantly detected in a subset of diffuse large B-cell lymphomas with extranodal presentation. Leukemia 20: 1300\u20131303","journal-title":"Leukemia"},{"key":"883_CR18","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1182\/blood.V94.5.1738","volume":"94","author":"Thompsett","year":"1999","unstructured":"Thompsett AR, Ellison DW, Stevenson FK et al. (1999) V(H) gene sequences from primary central nervous system lymphomas indicate derivation from highly mutated germinal center B cells with ongoing mutational activity. Blood 94: 1738\u20131746","journal-title":"Blood"},{"key":"883_CR19","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1182\/blood-2003-05-1465","volume":"103","author":"Montesinos-Rongen","year":"2004","unstructured":"Montesinos-Rongen M, Van Roost D, Schaller C et al. (2004) Primary diffuse large B-cell lymphomas of the central nervous system are targeted by aberrant somatic hypermutation. Blood 103: 1869\u20131875","journal-title":"Blood"},{"key":"883_CR20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/gcc.10093","volume":"35","author":"Jordanova","year":"2002","unstructured":"Jordanova ES, Riemersma SA, Philippo K et al. (2002) Hemizygous deletions in the HLA region account for loss of heterozygosity in the majority of diffuse large B-cell lymphomas of the testis and the central nervous system. Genes Chromosomes Cancer 35: 38\u201348","journal-title":"Genes Chromosomes Cancer"},{"key":"883_CR21","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1182\/blood.V96.10.3569","volume":"96","author":"Riemersma","year":"2000","unstructured":"Riemersma SA, Jordanova ES, Schop RF et al. (2000) Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites. Blood 96: 3569\u20133577","journal-title":"Blood"},{"key":"883_CR22","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1182\/blood-2005-04-1510","volume":"107","author":"Rimsza","year":"2006","unstructured":"Rimsza LM, Roberts RA, Campo E et al. (2006) Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions. Blood 107: 1101\u20131107","journal-title":"Blood"},{"key":"883_CR23","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0002-9440(10)65458-2","volume":"155","author":"Rickert","year":"1999","unstructured":"Rickert CH, Dockhorn-Dworniczak B, Simon R et al. (1999) Chromosomal imbalances in primary lymphomas of the central nervous system. Am J Pathol 155: 1445\u20131451","journal-title":"Am J Pathol"},{"key":"883_CR24","first-page":"737","volume":"63","author":"Nakamura","year":"2003","unstructured":"Nakamura M, Kishi M, Sakaki T et al. (2003) Novel tumor suppressor loci on 6q22\u201323 in primary central nervous system lymphomas. Cancer Res 63: 737\u2013741","journal-title":"Cancer Res"},{"key":"883_CR25","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1182\/blood-2005-03-0897","volume":"107","author":"Rubenstein","year":"2006","unstructured":"Rubenstein J, Fridlyand J, Shen A et al. (2006) Gene expression and angiotropism in primary CNS lymphoma. Blood 107: 3716\u20133723","journal-title":"Blood"},{"key":"883_CR26","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/gcc.20361","volume":"45","author":"Bosga-Bouwer","year":"2006","unstructured":"Bosga-Bouwer AG, Kok K, Booman M et al. (2006) Array comparative genomic hybridization reveals a very high frequency of deletions of the long arm of chromosome 6 in testicular lymphoma. Genes Chromosomes Cancer 45: 976\u2013981","journal-title":"Genes Chromosomes Cancer"},{"key":"883_CR27","unstructured":"Le Boit P BG, Weedon D, Sarasin A (2006) World Health Organization Classification of Tumours. Pathology and genetics of skin tumours. IARC, Lyon"},{"key":"883_CR28","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1200\/JCO.2005.02.0842","volume":"24","author":"Dijkman","year":"2006","unstructured":"Dijkman R, Tensen CP, Jordanova ES et al. (2006) Array-based comparative genomic hybridization analysis reveals recurrent chromosomal alterations and prognostic parameters in primary cutaneous large B-cell lymphoma. J Clin Oncol 24: 296\u2013305","journal-title":"J Clin Oncol"},{"key":"883_CR29","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1182\/blood-2004-04-1594","volume":"105","author":"Hoefnagel","year":"2005","unstructured":"Hoefnagel JJ, Dijkman R, Basso K et al. (2005) Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling. Blood 105: 3671\u20133678","journal-title":"Blood"},{"key":"883_CR30","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/01.cco.0000239879.31463.42","volume":"18","author":"Willemze","year":"2006","unstructured":"Willemze R (2006) Primary cutaneous B-cell lymphoma: classification and treatment. Curr Opin Oncol 18: 425\u2013431","journal-title":"Curr Opin Oncol"}],"container-title":["Der Pathologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-006-0883-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00292-006-0883-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-006-0883-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T17:03:31Z","timestamp":1587315811000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00292-006-0883-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["883"],"URL":"https:\/\/doi.org\/10.1007\/s00292-006-0883-5","relation":{},"ISSN":["0172-8113","1432-1963"],"issn-type":[{"value":"0172-8113","type":"print"},{"value":"1432-1963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}